Jubilant Biosys Limited
Rameshprabu Nallathambi is a Senior Research Scientist at Jubilant Biosys Limited since May 2023, where responsibilities include leading assay development and screening for integrated drug discovery projects globally. Previously, Rameshprabu served as a Senior Scientist at Sami-Sabinsa Group Limited, overseeing documentation and training junior staff. In an academic role as a Post Doctoral Associate at Rutgers University–New Brunswick from February 2018 to June 2019, Rameshprabu conducted NIH-funded research on botanical compounds for metabolic syndrome and related diseases. Earlier, as a Postdoctoral Fellow at ARO, Volcani Center, Rameshprabu worked independently on two research projects. Rameshprabu holds a PhD in Biology and a Master's in Biochemistry from Madurai Kamaraj University, along with a Bachelor's degree in Biochemistry from Periyar University.
This person is not in the org chart
This person is not in any offices
Jubilant Biosys Limited
1 followers
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.